(Q37896014)

25 August 2017

title

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer (English)

1 reference

25 August 2017

1 reference

5

Carlos Cordon-Cardo

1 reference

25 August 2017

1

Matthew S Wosnitzer

1 reference

25 August 2017

Gregory W Hruby

2

1 reference

25 August 2017

Alana M Murphy

3

1 reference

25 August 2017

Lamont J Barlow

4

1 reference

25 August 2017

Mahesh Mansukhani

6

1 reference

25 August 2017

Daniel P Petrylak

7

1 reference

25 August 2017

Mitchell C Benson

8

1 reference

25 August 2017

James M McKiernan

9

1 reference

25 August 2017

language of work or name

English

0 references

publication date

29 June 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

118

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

358-364

1 reference

25 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

Cystectomy for bladder cancer: a contemporary series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26278

7 January 2021

Identifiers

DOI

10.1002/CNCR.26278

1 reference

25 August 2017

1 reference